Marginal Donors in Liver Transplantation: Expanding the Donor Pool

Journal of Surgical Education

Volumn 64, Issue 1, 2007, Pages 46-50

  Nadig, Satish N ^a   Bratton, Charles F ^b   Karp, Seth J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

donation after cardiac death; hepatitis; liver transplant; marginal donor; split liver; steatosis

Indexed keywords

HEPATITIS B ANTIBODY; LAMIVUDINE;

ARTICLE; CADAVER DONOR; COMBINATION CHEMOTHERAPY; DIALYSIS; DONOR SELECTION; EXPERIMENTATION; FATTY LIVER; GRAFT SURVIVAL; HEART DEATH; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; LIVER GRAFT; LIVER RESECTION; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MONOTHERAPY; ORGAN DONOR; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURGICAL TECHNOLOGY; VIRUS TRANSMISSION; XENOTRANSPLANTATION;

DEATH; FATTY LIVER; HEPATITIS B; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 33847081647     PISSN: 19317204     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cursur.2006.08.001     Document Type: Article

References (26)

1. Marsman W.A., Wiesner R.H., Rodriguez L., et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62 (1999) 1246-1251
2. Cheng Y.F., Chen C.L., Lai C.Y., et al. Assessment of donor fatty livers for liver transplantation. Transplantation 71 (2001) 1221-1225
3. Chavin K.D., Fiorini R.N., Shafizadeh S., et al. Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation. Am J Trans 4 (2004) 1440-1447
4. Crowley H., Lewis W.D., Gordon F., Jenkins R., and Khettry U. Staetosis in donor and transplant liver biopsies. Hum Pathol 31 (2000) 1209-1213
5. Busuttil R.W., and Tanaka K. The utility of marginal donors in liver transplantation. Liver Trans 9 (2003) 651-663
6. Nadig S.N., Periyasamy B., Shafizadeh S.F., et al. Hepatocellular ultrastructure after ischemia/reperfusion injury in human orthotopic liver transplantation. J Gastrointest Surg 8 (2004) 695-700
7. Emond J.C., Ascher N.L., and Busuttil R.W. Split liver transplantation in the United States: creation of a national registry and preliminary outcomes. Am J Transplant 1 suppl 1 (2000) 260
8. Couinaud C. Le Foie, Etudes Anatomiques et Chirurgicales (1957), Masson, Paris
9. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 6 (1982) 3-9
10. Emond J.C., Freeman Jr. R.B., Renz J.F., Yersiz H., Rogiers X., and Busuttil R.W. Optimizing the use of donated cadaver livers: analysis and policy development to increase the application of split-liver transplantation. Liver Transplant 8 (2002) 863-872
11. Ghobrial R.M., Yersiz H., Farmer D.G., et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 232 (2000) 312-323
12. Yersiz H., Renz J.F., Farmer D.G., Hisatake G.M., McDiarmid S.V., and Busuttil R.W. One hundred in situ split-liver transplantations: a single center experience. Ann Surg 238 (2003) 496-507
13. Humar A., Ramcharan T., Sielaff T.D., et al. Split liver transplantation for two adult recipients: an initial experience. Am J Trans 1 (2001) 366-372
14. Baccarani U., Adani G.L., Risaliti A., et al. Long-term results of in situ split-liver transplantation. Trans Proc 37 (2005) 2592-2594
15. van Der Hoeven J.A., Ter Horst G.J., Molema G., et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 232 (2000) 804-813
16. Jassem W., Koo D.D., Muiesan P., et al. Non-heart-beating versus cadaveric and living-donor livers: differences in inflammatory markers before transplantation. Transplantation 75 (2003) 1386-1390
17. Abt P.L., Desai N.M., Crawford M.D., et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 239 1 (2004) 87-92
18. Reddy S., Zilvetti M., Brockmann J., McLaren A., and Friend P. Liver transplantation from non-heart-beating donors: current status and future prospects. Liver Transplant 10 (2004) 1223-1232
19. Alter M.J. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1 (1997) 559-568 vi-vii
20. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 1 (2001) 41-52
21. Testa G., Goldstein R.M., Netto G., et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 65 (1998) 925-929
22. Buendia M.A. Hepatitis B viruses and cancerogenesis. Biomed Pharmacother 52 (1998) 34-43
23. Castells L., Vargas V., Rodriguez-Frias F., et al. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Transplant Proc 31 (1999) 2464-2465
24. Uemoto S., Inomata Y., Sannomiya A., et al. Posttransplant hepatitis B infection in liver transplantation with hepatitis B core antibody- positive donors. Transplant Proc 30 (1998) 134-135
25. Saab S., Chang A.J., Comulada S., et al. Outcomes of hepatitis C- and hepatitis B core antibody positive grafts in orthotopic liver transplantation. Liver Transplant 9 (2003) 1053-1061
26. Kootstra G., Daemen J.H., and Oomen A.P. Categories of non-heart-beating donors. Transplant Proc 27 (1995) 2893-2894